Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin in ICU Anemia Feasibility Study
NCT05080049Phase 3Unknown
- Sponsor
- Centre Hospitalier Universitaire d'Angers
- Start
- Jan 2022
- Primary completion
- Sep 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of erythropoietin in anemia, sponsored by Centre Hospitalier Universitaire d'Angers. Status: unknown.
02
Drugs
erythropoietin
03
Conditions
anemia
Beyond the preview
Go deeper on NCT05080049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05080049.